Kak,
I agree with your comments (in part) about managt and just as disappointed where the SP is at. Yes - I think managt could have been more proactive but really we don’t know all the facts so I reserve my judgement.
All I'm saying is the MPC technology has impressed many including but not limited to TEVA , Lonza , analysts , industry stakeholders ( Evaluate Pharma , Eric Rose Medical Director/Scholar/Specialist ) , industry heavyweights ( W Burns - Roche; J Symmons - Novartis) ; and fund managers ( M& G; Capital; Black Rock) .
WE are a still an ASX 200 company (3 years now), we have a CEO who has been acknowledged by many as a pioneer in stem cell research , a confident extremely proud individual and In December 2014..... it will be 10 years since the Blaster listed in the ASX.
In my opinion only, I think the time is coming.
Please DYOR.
Kak, I agree with your comments (in part) about managt and just...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
-0.040(3.76%) |
Mkt cap ! $1.170B | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.07 | $1.01 | $13.19M | 12.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 61090 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 239558 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |